CTRI/2026/04/107495Not yet recruitingPhase 2
Role of Growth Factor Concentrate in Androgenetic Alopecia- a hospital based comparative study
srms medical college1 site in 1 country30 target enrollmentStarted: April 15, 2026Last updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 30
- Locations
- 1
Study Overview
Brief Summary
This is a trial to compare the effects of growth factor concentrate vs topical minoxidil for treatment of Androgenetic alopecia. The results will be evaluated based on Norwood-Hamilton score, Ludwig score, Sinclaire grading and Modified global photographic assessment score which will be recorded on every visit. Sittings will be done at monthly intervals for 3 months and then at 6 months. At the end of 6 months, comparison will be done based on these scores.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Masking
- None
Eligibility Criteria
- Ages
- 18.00 Year(s) to 60.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •All diagnosed with stable type of Androgenetic alopecia.
- •Patients with hair type II-V according to Norwood-Hamilton scale for males.
- •Patients with hair type I-II according to Ludwig scale for females.
- •Patients who are willing to abstain from other treatments.
- •Patients who have completed written consent form.
Exclusion Criteria
- •Patients who refused to participate.
- •Patients with other type of alopecia as a diagnosis.
- •Patients suffering from seborrheic dermatitis, tines capitis or any other scalp infection.
- •Patients undergoing any form of chemo or radiotherapy.
- •Patients found to be allergic to constituents of GFC.
- •Pregnant and lactating females, chronic smokers or alcoholics.
- •Patients who have taken any treatment for past 3 months.
Investigators
Tanvi Singla
Shri ram murti smarak institute of medical sciences
Study Sites (1)
Loading locations...
Similar Trials
Not yet recruiting
Phase 4
Comparing effectiveness of topical minoxidil versus topical minoxidil with dutasteride injections in male patients with male pattern hair lossCTRI/2024/08/071840Dr. Meenal Agrawal76
Not yet recruiting
Phase 1
Comparision of autologous Growth Factor Concentrate injection versus Platelet Rich Plasma injection in patients of Androgenic Alopecia receiving topical minoxidilCTRI/2024/09/073394Shini Choubey44
Unknown
Not Applicable
请再 IPD 平台上传原始数据。 自体浓缩生长因子联合米诺地尔治疗男性雄激素源性脱发的随机自身对照临床试验男性雄激素源性脱发ChiCTR2000030161自筹16
Recruiting
Phase 4
Oral vs. Topical Minoxidil with PRP: A Revolutionary Trial for Androgenetic AlopeciaCTRI/2025/03/082606Dr Paridhi Vaidh60
Unknown
Not Applicable
评估浓缩生长因子联合米诺地尔与微针联合米诺地尔治疗女性雄激素性秃发的有效性和安全性的随机自身对照临床试验ChiCTR2500100772山西振东安欣生物制药有限公司